Liquid Biopsy Detects DNA Markers in Advanced Breast Cancer Within Five Hours

Liquid Biopsy Detects DNA Markers in Advanced Breast Cancer Within Five Hours

A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can accurately detect the presence of cancer DNA in the blood of patients with metastatic breast cancer within five hours. The test, currently a prototype for research use only, potentially could be used to quickly help oncologists determine if cancer treatments are working. Learn more here.

Recent Posts
New Blood Test for Cancer The Best Way to Take A Pill, According to Science 8 Ways to Lose Belly Fat and Live a Healthier Life Sunglasses Are More Than Just a Fashion Accessory Living Better with Brain Cancer DNA Shed From Colon Cancers Into Bloodstream Guide Chemotherapy New Treatment Protocols for Early Stage Lung Cancer Johns Hopkins Medicine Researchers Awarded Nearly $8 Million from Break Through Cancer Foundation The Importance of Cancer Screening